Palvella Therapeutics, Inc (PVLA) earnings · rev $42.8M
These earnings events as JSON? API free 100/dayPalvella Therapeutics, Inc (PVLA) is a biotechnology company listed on NASDAQ.
This PVLA earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported PVLA revenue for 2023-12-31 was $42.8M. Net income was -$24.5M. Revenue was up 65.3% from 2022-12-31 to 2023-12-31. PVLA currently screens at market cap $1.64B.
When the next PVLA 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 65.3% from 2022-12-31 to 2023-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full PVLA research stays on the stock page; the tape stays on the quote page.
PVLA earnings FAQ
What are PVLA's latest revenue and net income?
Latest cached Palvella Therapeutics, Inc (PVLA) revenue for Dec 31, 2023 was $42.8M. Net income was -$24.5M. Statements: https://lician.com/financials/pvla
What period does the latest PVLA earnings print cover?
The latest cached Palvella Therapeutics, Inc (PVLA) earnings print covers Dec 31, 2023. The prior cached period on this page is Dec 31, 2022.
How did PVLA revenue change from the prior cached period?
Cached Palvella Therapeutics, Inc (PVLA) revenue was up 65.3% from $25.9M (Dec 31, 2022) to $42.8M (Dec 31, 2023). Statements: https://lician.com/financials/pvla
Where are PVLA earnings listed?
Cached earnings facts for Palvella Therapeutics, Inc (PVLA) are listed at https://lician.com/earnings/pvla. Statements: https://lician.com/financials/pvla
Not investment advice.